According to Saturday’s Nikkei, UK pharmaceutical company AstraZeneca has launched in Japan a clinical test of its coronavirus vaccine, saying that some 250 healthy people aged 18 or over will participate in the two-stage trial conducted at several hospitals. The drug manufacturer is reportedly aiming to supply 30 million doses of its COVID 19 vaccine to the Japanese market by next March.